FDA approves Medtronic DF4 High-Voltage Connector System for ICDs and CRT-Ds

Medtronic, Inc. (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval and launch of the DF4 High-Voltage Connector System, a right ventricular lead and connector used with implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) to detect and accurately treat potentially life-threatening heart rhythms. The DF4 Connector System helps simplify implantation procedures via a redesigned port and provides additional reliability by giving physicians visual confirmation of the lead connection to the device.

“It's a lead tested by time, coupled with the latest technological advancements.”

The DF4 connector uses the same lead body as Medtronic's Sprint Quattro® lead, which has more than a decade of proven performance and a high safety and efficacy profile. The DF4 design includes fewer connections between the device and the defibrillation leads. Prior to the development of the DF4, traditional high-voltage connector systems required up to three connections. The DF4 connector has a single set-screw to connect the lead to the device and is available on several Medtronic ICDs and CRT-Ds, including the Protecta®, Consulta® and Secura® portfolio of implantable defibrillators.

"With the availability of the DF4 system, implanting physicians now have access to the newest industry standard designed specifically around implant simplicity and system reliability," said Brian Ramza, M.D., Evangeline and Frank Thompson chair in electrophysiology at the St. Luke's Mid America Heart Institute in Kansas City, Mo. "This innovation addresses our need for easy-to-use, reliable technology that helps shorten the overall procedure time without compromising safety."

In addition to the U.S., the DF4 High-Voltage Connector System is approved for use and available in most geographies including Europe, Japan, Canada, and Australia.

"Medtronic is bringing U.S. physicians the reliability of the Quattro lead, which has 10 years of proven performance, along with the newest innovation in connection systems," said Pat Mackin, president of the Cardiac Rhythm Disease Management business and senior vice president at Medtronic. "It's a lead tested by time, coupled with the latest technological advancements."

Source:

 Medtronic

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Medtronic. (2019, June 24). FDA approves Medtronic DF4 High-Voltage Connector System for ICDs and CRT-Ds. News-Medical. Retrieved on May 28, 2022 from https://www.news-medical.net/news/20120130/FDA-approves-Medtronic-DF4-High-Voltage-Connector-System-for-ICDs-and-CRT-Ds.aspx.

  • MLA

    Medtronic. "FDA approves Medtronic DF4 High-Voltage Connector System for ICDs and CRT-Ds". News-Medical. 28 May 2022. <https://www.news-medical.net/news/20120130/FDA-approves-Medtronic-DF4-High-Voltage-Connector-System-for-ICDs-and-CRT-Ds.aspx>.

  • Chicago

    Medtronic. "FDA approves Medtronic DF4 High-Voltage Connector System for ICDs and CRT-Ds". News-Medical. https://www.news-medical.net/news/20120130/FDA-approves-Medtronic-DF4-High-Voltage-Connector-System-for-ICDs-and-CRT-Ds.aspx. (accessed May 28, 2022).

  • Harvard

    Medtronic. 2019. FDA approves Medtronic DF4 High-Voltage Connector System for ICDs and CRT-Ds. News-Medical, viewed 28 May 2022, https://www.news-medical.net/news/20120130/FDA-approves-Medtronic-DF4-High-Voltage-Connector-System-for-ICDs-and-CRT-Ds.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
Medtronic launches GenCut Core Biopsy System for minimally invasive use with the superDimension navigation system for lung tissue biopsies